Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Leilani Sanchez"'
Autor:
Leilani Sanchez, Osamu Matsuoka, Satoshi Inoue, Takahiro Inoue, Ya Meng, Takahiro Nakama, Kumiko Kato, Aseem Pandey, Lee-Jah Chang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 4, Pp 858-866 (2020)
A trivalent high-dose inactivated influenza vaccine has been licensed in healthy adults ≥65 years of age and provides better protection against influenza infection and related complications than trivalent standard-dose vaccine. This phase I/II clin
Externí odkaz:
https://doaj.org/article/42e8497c01b542748034caec031a722d
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
B6.Sle1.Sle2.Sle3 (B6.TC) lupus-prone mice carrying the NZB allele of Cdkn2c, encoding for the cyclin-dependent kinase inhibitor P18INK4, accumulate B-1a cells due to a higher rate of proliferative self-renewal. However, it is unclear whether this af
Externí odkaz:
https://doaj.org/article/24c19b5297124232825114577a4c6691
Autor:
Leilani Sanchez, Takahiro Nakama, Hideaki Nagai, Osamu Matsuoka, Satoshi Inoue, Takahiro Inoue, Anju Shrestha, Aseem Pandey, Lee-Jah Chang, Iris De Bruijn
Publikováno v:
Vaccine. 41:2553-2561
Autor:
Leilani Sanchez, Supattra Rungmaitree, Pope Kosalaraksa, Watsamon Jantarabenjakul, Julie Leclercq, Yuvadee Yaiprayoon, Venkata Jayanth Midde, Kucku Varghese, Somnath Mangarule, Fernando Noriega
Publikováno v:
Pediatric Infectious Disease Journal.
Autor:
Leilani Sanchez, Ana Paula Perroud, Gustavo H. Dayan, Tifany Machabert, Humberto Reynales, Betzana Zambrano, Claire Vigne, Stephen Savarino, Thelma Laot, Sri Rezeki Hadinegoro, Carlos A. DiazGranados, Owen Haney, Matthew Bonaparte, Alex Luedtke, Diana Coronel, Danaya Chansinghakul, Fernando Noriega, Yukun Wu, Alain Bouckenooghe, Maria Rosario Capeding, Brenda L. Price, Carina Frago, Remi Forrat
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background CYD-TDV, a live, attenuated, tetravalent dengue vaccine, has been approved for the prevention of symptomatic dengue in previously dengue exposed individuals. This post hoc analysis assessed hospitalized and severe virologically confirmed d
Autor:
Leilani Sanchez, Ana Paula Perroud, Sophia Gailhardou, Sri Rezeki Hadinegoro, Fernando Noriega, Danaya Chansinghakul, Tram Anh Wartel, Tawee Chotpitayasunondh, Dewa Nyoman Wirawan, D M Rivera Medina, Thelma Laot, José Luis Arredondo-García, Matthew Bonaparte, Humberto Reynales, Kriengsak Limkittikul, Alain Bouckenooghe, Diana Coronel, Carina Frago, M N Chua, M Cortés Supelano, Carmen Deseda, N H Tran, Betzana Zambrano, Edith Langevin
Publikováno v:
Clinical Microbiology and Infection. 24:755-763
Our objective was to describe the risk of hospital admission for virologically confirmed dengue (VCD) and the risk of clinically severe hospitalized VCD occurring up to 4 years after the first dose (years 1 to 4) in three randomized clinical trials c
Autor:
Leilani Sanchez, Osamu Matsuoka, Takahiro Nakama, Ya Meng, Lee-Jah Chang, Kumiko Kato, Satoshi Inoue, Aseem Pandey, Takahiro Inoue
Publikováno v:
Human Vaccines & Immunotherapeutics
A trivalent high-dose inactivated influenza vaccine has been licensed in healthy adults ≥65 years of age and provides better protection against influenza infection and related complications than trivalent standard-dose vaccine. This phase I/II clin